Antigen-presenting cell activation: a link between infection and autoimmunity?

PubWeight™: 0.82‹?›

🔗 View Article (PMID 11334496)

Published in J Autoimmun on May 01, 2001

Authors

S Kissler1, S M Anderton, D C Wraith

Author Affiliations

1: Department of Pathology and Microbiology, University of Bristol, Bristol, UK.

Articles by these authors

Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell (1988) 5.73

Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity (1995) 3.18

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature (1996) 2.30

An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int Immunol (1993) 2.06

Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol (1993) 1.82

Lowering the tone: mechanisms of immunodominance among epitopes with low affinity for MHC. Immunol Today (1996) 1.81

Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol (1999) 1.78

Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med (1993) 1.71

Induction of influenza A virus cross-reactive cytotoxic T cells by a nucleoprotein/haemagglutinin preparation. J Gen Virol (1985) 1.70

Purified influenza virus nucleoprotein protects mice from lethal infection. J Gen Virol (1987) 1.62

Negative selection during the peripheral immune response to antigen. J Exp Med (2001) 1.59

A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (1991) 1.45

Changing incidence of primary total hip arthroplasty and total knee arthroplasty for primary osteoarthritis. J Arthroplasty (2002) 1.39

Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo. Int Immunol (1999) 1.31

Mite asthma. Cause and management. Practitioner (1970) 1.27

Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice--implications for autoimmunity. Int Immunol (1995) 1.13

Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases? Immunol Today (1998) 1.12

Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc Natl Acad Sci U S A (1997) 1.10

Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin. Eur J Immunol (1998) 1.09

Control of immune interferon release by cytotoxic T-cell clones specific for influenza. Immunology (1985) 1.08

Translational mini-review series on Th17 cells: CD4 T helper cells: functional plasticity and differential sensitivity to regulatory T cell-mediated regulation. Clin Exp Immunol (2009) 1.04

Qualitative and quantitative effects of CD28/B7-mediated costimulation on naive T cells in vitro. J Immunol (1998) 0.99

Influenza peptide-induced self-lysis and down-regulation of cloned cytotoxic T cells. Immunology (1990) 0.99

Fine specificity of the myelin-reactive T cell repertoire: implications for TCR antagonism in autoimmunity. J Immunol (1998) 0.97

The nature of cryptic epitopes within the self-antigen myelin basic protein. Int Immunol (1996) 0.95

Encephalitogenic epitopes of myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H-2Ag7) mice share an amino acid motif. J Immunol (1996) 0.95

Detection of autoreactive T cells in H-2u mice using peptide-MHC multimers. Int Immunol (2000) 0.95

Complete characterization of the expressed immune response genes in Biozzi AB/H mice: structural and functional identity between AB/H and NOD A region molecules. Immunogenetics (1993) 0.93

Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitis. Ann N Y Acad Sci (1996) 0.93

Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells. Neuropathol Appl Neurobiol (2011) 0.92

Preparing for first-in-man studies: the challenges for translational immunology post-TGN1412. Clin Exp Immunol (2008) 0.91

Influenza virus-specific cytotoxic T-cell recognition: stimulation of nucleoprotein-specific clones with intact antigen. Immunology (1986) 0.90

The role of polymorphic I-Ak beta chain residues in presentation of a peptide from myelin basic protein. J Exp Med (1989) 0.90

Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein. J Immunol (1989) 0.89

Inhibition of T-cell responsiveness by nasal peptide administration: influence of the thymus and differential recovery of T-cell-dependent functions. Immunology (1999) 0.88

Kinetics of peptide uptake and tissue distribution following a single intranasal dose of peptide. Immunol Invest (2000) 0.87

T cell responses to conserved bacterial heat-shock-protein epitopes induce resistance in experimental autoimmunity. Semin Immunol (1998) 0.86

Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease. Immunology (1994) 0.86

Differential responses of CD45+ve T-cell subsets to MBP in multiple sclerosis. Clin Exp Immunol (2001) 0.84

Diversity and dynamics of the T-cell response to MBP in DR2+ve individuals. Clin Exp Immunol (2002) 0.83

(Altered) self peptides and the regulation of self reactivity in the peripheral T cell pool. Immunol Rev (1996) 0.82

Immunotherapy of autoimmune disease. Curr Opin Immunol (1993) 0.82

Loss of serological determinants does not affect recognition of H-2Kk target cells by an influenza-specific cytotoxic T cell clone. Eur J Immunol (1983) 0.82

Peptide-MHC interaction in autoimmunity. Curr Opin Immunol (1992) 0.81

Therapeutic potential of TCR antagonists is determined by their ability to modulate a diverse repertoire of autoreactive T cells. Eur J Immunol (1999) 0.81

Splenic but not thymic autoreactive T cells from New Zealand Black mice respond to a dominant erythrocyte Band 3 peptide. Immunology (1999) 0.80

Evolution, function, and utilization of major histocompatibility complex polymorphism in autoimmune disease. Cold Spring Harb Symp Quant Biol (1989) 0.78

Dk-restricted antiinfluenza cytotoxic T-cell clone loses one of its two alloreactivities. Immunogenetics (1984) 0.78

Identification of an indirectly presented epitope in a mouse model of skin allograft rejection. Transplantation (1998) 0.78

Differential rat T cell recognition of cathepsin D-released fragments of mycobacterial 65 kDa heat-shock protein after immunization with either the recombinant protein or whole mycobacteria. Int Immunol (1994) 0.78

Antigen-specific tolerance induction and the immunotherapy of experimental autoimmune disease. Novartis Found Symp (1998) 0.77

Cytotoxic T-cell recognition of influenza-infected target cells varies in different H-2k mouse strains. Immunogenetics (1983) 0.77

Viral respiratory tract infections and asthma in early life: cause and effect? Clin Exp Allergy (2014) 0.76

Ability of T cells from patients with rheumatoid arthritis to respond to immunoglobulin G. Immunology (1999) 0.75

Cell-surface remodelling during mammalian erythropoiesis. Biochem J (1982) 0.75

Anti-class II MHC antibodies prevent and treat EAE without APC depletion. Immunology (1994) 0.75

Immunotherapy of autoimmune disease with synthetic peptides. Immunol Today (1994) 0.75

Tolerance to an arthritogenic T-cell epitope of HSP65 and the regulation of experimental arthritis. Ann N Y Acad Sci (1996) 0.75

Specific immunity as a critical factor in the control of autoimmune arthritis: the example of hsp60 as an ancillary and protective autoantigen. Scand J Rheumatol Suppl (1995) 0.75

Recognition of H-2Kk variant cells by an antiinfluenza cytotoxic T-cell clone. Transplant Proc (1983) 0.75

Specific immunological non-responsiveness induced by antigens via mucosal surfaces. Adv Exp Med Biol (1995) 0.75

Fine specificity of myelin basic protein reactive T-cells: implications for T-cell receptor antagonism. Biochem Soc Trans (1997) 0.75

Processing of myelin basic protein by macrophages generates an epitope with apparent low affinity for I-As. Biochem Soc Trans (1995) 0.75

Prolongation of murine vascularized heart allograft survival by recipient-specific anti-major histocompatibility complex class II antibody. Transplantation (1997) 0.75

MHC binding peptides as therapeutic agents. Clin Exp Rheumatol (1993) 0.75

Modulation of cytokine production following intranasal administration of antigenic peptide. Transplant Proc (1998) 0.75